Topics

MEDNAX Reports First Quarter GAAP EPS from Continuing Operations of $0.48; Adjusted EPS from Continuing Operations of $0.65

06:00 EDT 2 May 2019 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
Results Reflect Classification of MedData as Discontinued Operations MEDNAX, Inc. (NYSE: MD), the national health solutions partner specializing in neonatology, anesthesiology, radiology, maternal-fetal medicine, other pedia...

Other Sources for this Article

Charles Lynch
Vice President, Strategy and Investor Relations
954-384-0175, x 5692
charles_lynch@mednax.com

NEXT ARTICLE

More From BioPortfolio on "MEDNAX Reports First Quarter GAAP EPS from Continuing Operations of $0.48; Adjusted EPS from Continuing Operations of $0.65"

Quick Search

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Anesthesiology
An anesthesiologist (US English) or anaesthetist (British English) is a physician trained in anesthesia and perioperative medicine. Anesthesiologists are physicians who provide medical care to patients in a wide variety of (usually acute) situations. ...

Radiology
Radiology is the branch of medicine that studies imaging of the body; X-ray (basic, angiography, barium swallows), ultrasound, MRI, CT and PET. These imaging techniques can be used to diagnose, but also to treat a range of conditions, by allowing visuali...